Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Bromfenac Sodium (AHR 10282R) is a nonsteroidal anti-inflammatory drug (NSAID), which has anti-inflammatory activity and may block prostaglandin synthesis by inhibiting cyclooxygenase 1 and 2.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
10 mg | In stock | $ 47.00 | |
25 mg | In stock | $ 75.00 | |
50 mg | In stock | $ 97.00 | |
100 mg | In stock | $ 122.00 | |
200 mg | In stock | $ 183.00 | |
500 mg | In stock | $ 297.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 45.00 |
Description | Bromfenac Sodium (AHR 10282R) is a nonsteroidal anti-inflammatory drug (NSAID), which has anti-inflammatory activity and may block prostaglandin synthesis by inhibiting cyclooxygenase 1 and 2. |
Targets&IC50 | COX-2:7.45 nM (IC50), COX-1:5.56 nM (IC50) |
Synonyms | AHR 10282B, Bronuck, AHR 10282R |
Molecular Weight | 356.15 |
Formula | C15H11BrNO3·Na |
CAS No. | 91714-93-1 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
H2O: 65 mg/mL (182.5 mM)
Ethanol: 2 mg/mL (5.61 mM)
DMSO: 66 mg/mL (185.3 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Bromfenac Sodium 91714-93-1 Immunology/Inflammation Neuroscience COX AHR 10282B Inhibitor inhibit Bromfenac Cyclooxygenase HLEC-B3 Bronuck AHR 10282R ocular inflammation inhibitor